{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T04:59:46Z","timestamp":1790312386928,"version":"4.1.0"},"reference-count":223,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010408","name":"Polpharma Scientific Foundation","doi-asserted-by":"publisher","award":["1\/XXII\/2024"],"award-info":[{"award-number":["1\/XXII\/2024"]}],"id":[{"id":"10.13039\/501100010408","id-type":"DOI","asserted-by":"publisher"}]},{"award":["1\/XXII\/2024"],"award-info":[{"award-number":["1\/XXII\/2024"]}],"id":[{"id":"https:\/\/ror.org\/01978ee63","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. J. Mol. Sci.","IJMS"],"abstract":"<jats:p>Adjuvant treatments for IDH-wild-type adult high-grade gliomas (HGGs) are being explored to improve therapeutic efficacy. Tumor hypoxia poses a major therapeutic challenge. In this narrative review, we discuss the potential of hyperbaric oxygen to counteract hypoxia and therapeutic resistance in HGG, with particular emphasis on glioblastoma. We delineate the pros and cons of combining treatment with hyperbaric oxygen (HBO) with established and experimental treatments for glioblastoma. HBO has been investigated as an adjuvant treatment alongside radiotherapy and chemotherapy, including new investigational compounds and approaches, with predominantly favorable outcomes in overall treatment efficacy. Among the numerous anticancer phytopharmaceuticals and nutraceuticals in this treatment paradigm, research on curcumin and its derivatives may lay the groundwork for promising future research directions and new chemical syntheses. The growing body of laboratory and clinical data suggests that HBO should be considered a promising component of modern oncological strategies for patients with HGG. However, further studies are needed to substantiate the effects of HBO since it has also been associated with increased tumor proliferation in some studies. Moreover, further studies are needed to substantiate the effects of HBO on tumor\/immune interactions, stemness, therapy resistance, and patients\u2019 quality of life.<\/jats:p>","DOI":"10.3390\/ijms27198504","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T16:10:31Z","timestamp":1790179831000},"page":"8504","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Anti-Glioma Agents and Hyperbaric Oxygen for Prospective Therapeutic Approaches"],"prefix":"10.3390","volume":"27","author":[{"given":"Emanuela B.","family":"Pucko","sequence":"first","affiliation":[{"name":"Department of Neurooncology, Mossakowski Medical Research Institute, Polish Academy of Sciences (MMRI-PAS), 02-106 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakub","family":"Godlewski","sequence":"additional","affiliation":[{"name":"Department of Neurooncology, Mossakowski Medical Research Institute, Polish Academy of Sciences (MMRI-PAS), 02-106 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4671-966X","authenticated-orcid":false,"given":"Natalia","family":"Ka\u017amierczak","sequence":"additional","affiliation":[{"name":"Faculty of Biotechnology and Food Sciences, \u0141\u00f3d\u017a University of Technology, 90-530 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert P.","family":"Ostrowski","sequence":"additional","affiliation":[{"name":"Department of Neurooncology, Mossakowski Medical Research Institute, Polish Academy of Sciences (MMRI-PAS), 02-106 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,23]]},"reference":[{"key":"ref_1","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Ostrowski, R.P., Acewicz, A., He, Z.H., Pucko, E.B., and Godlewski, J. (2025). Environmental Hazards and Glial Brain Tumors: Association or Causation?. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26157425"},{"key":"ref_3","first-page":"3","article-title":"Glioblastoma Multiforme: A Review of its Epidemiology and Pathogenesis through Clinical Presentation and Treatment","volume":"18","author":"Hanif","year":"2017","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO Classification of Tumors of the Central Nervous System: A summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro-Oncology"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Obrador, E., Moreno-Murciano, P., Oriol-Caballo, M., L\u00f3pez-Blanch, R., Pineda, B., Guti\u00e9rrez-Arroyo, J.L., Loras, A., Gonzalez-Bonet, L.G., Martinez-Cadenas, C., and Estrela, J.M. (2024). Glioblastoma Therapy: Past, Present and Future. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25052529"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.wneu.2014.12.009","article-title":"Radiation-induced malignant gliomas: A current review","volume":"83","author":"Elsamadicy","year":"2015","journal-title":"World Neurosurg."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S1470-2045(22)00655-6","article-title":"Brain cancer after radiation exposure from CT examinations of children and young adults: Results from the EPI-CT cohort study","volume":"24","author":"Hauptmann","year":"2023","journal-title":"Lancet Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"934","DOI":"10.18632\/oncoscience.278","article-title":"Mouse models of radiation-induced glioblastoma","volume":"2","author":"Mukherjee","year":"2015","journal-title":"Oncoscience"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"vdab109","DOI":"10.1093\/noajnl\/vdab109","article-title":"Defining the molecular features of radiation-induced glioma: A systematic review and meta-analysis","volume":"3","author":"Whitehouse","year":"2021","journal-title":"Neuro-Oncol. Adv."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Langen, K.J., Galldiks, N., Mauler, J., Kocher, M., Fil\u00df, C.P., Stoffels, G., R\u00e9gio Brambilla, C., Stegmayr, C., Willuweit, A., and Worthoff, W.A. (2023). Hybrid PET\/MRI in Cerebral Glioma: Current Status and Perspectives. Cancers, 15.","DOI":"10.20944\/preprints202306.0090.v1"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Mishra, P., Gupta, P., Markowska, A., Ghavami, S., Markowski, J., and \u0141os, M.J. (2026). Advancements in Drug Delivery Systems in Glioblastoma Therapy. Int. J. Mol. Sci., 27.","DOI":"10.3390\/ijms27052298"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Serventi, J., and Mohile, N. (2026). Person-Centered Care in Glioblastoma: The Art of Early Advance Care Planning. Cancers, 18.","DOI":"10.3390\/cancers18030413"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1001\/jama.2015.16669","article-title":"Maintenance Therapy with Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma: A Randomized Clinical Trial","volume":"314","author":"Stupp","year":"2015","journal-title":"JAMA"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12943-025-02267-0","article-title":"Glioblastoma multiforme: Insights into pathogenesis, key signaling pathways, and therapeutic strategies","volume":"24","author":"Pouyan","year":"2025","journal-title":"Mol. Cancer"},{"key":"ref_15","first-page":"oyae227","article-title":"Recent advances in Tumor Treating Fields (TTFields) therapy for glioblastoma","volume":"30","author":"Khagi","year":"2025","journal-title":"Oncology"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"60190","DOI":"10.12775\/QS.2025.41.60190","article-title":"Optune in Glioblastoma: Revolutionizing Treatment with Tumor Treating Fields","volume":"41","author":"Kozakiewicz","year":"2025","journal-title":"Qual. Sport"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1001\/jamaoncol.2017.5082","article-title":"Influence of Treatment with Tumor-Treating Fields on Health-Related Quality of Life of Patients with Newly Diagnosed Glioblastoma: A Secondary Analysis of a Randomized Clinical Trial","volume":"4","author":"Taphoorn","year":"2018","journal-title":"JAMA Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Stein, M., Dohmen, H., W\u00f6lk, B., Eberle, F., Kolodziej, M., Acker, T., Uhl, E., and Jensen, A. (2020). Case Report of Complete Radiological Response of a Thalamic Glioblastoma After Treatment with Proton Therapy Followed by Temozolomide and Tumor-Treating Fields. Front. Oncol., 10.","DOI":"10.3389\/fonc.2020.00477"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"vdae032","DOI":"10.1093\/noajnl\/vdae032","article-title":"Tumor-treating fields dosimetry in glioblastoma: Insights into treatment planning, optimization, and dose\u2013response relationships","volume":"6","author":"Mikic","year":"2024","journal-title":"Neuro-Oncol. Adv."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.21037\/atm-21-4395","article-title":"Multiple subtentorial metastasis in diffuse midline glioma receiving tumor treating fields: A case report and literature review","volume":"9","author":"Liang","year":"2021","journal-title":"Ann. Transl. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/j.1582-4934.2011.01258.x","article-title":"Why is the partial oxygen pressure of human tissues a crucial parameter? Small molecules and hypoxia","volume":"15","author":"Carreau","year":"2011","journal-title":"J. Cell. Mol. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1093\/jnci\/93.4.266","article-title":"Tumor hypoxia: Definitions and current clinical, biologic, and molecular aspects","volume":"93","author":"Vaupel","year":"2001","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s10555-007-9055-1","article-title":"Hypoxia in cancer: Significance and impact on clinical outcome","volume":"26","author":"Vaupel","year":"2007","journal-title":"Cancer Metastasis Rev."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Pleskacova, Z., Bartos, M., Vosmikova, H., Dolezal, R., Krupa, P., Vitovcova, B., Kasparova, P., Rudolf, E., Skarkova, V., and Pohankova, D. (2024). Prognostic Factors for Survival in Glioblastoma: A Retrospective Analysis Focused on the Role of Hemoglobin. Biomedicines, 12.","DOI":"10.3390\/biomedicines12061210"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1186\/s13046-021-02082-7","article-title":"The HIF1\u03b1-PDGFD-PDGFR\u03b1 axis controls glioblastoma growth at normoxia\/mild-hypoxia and confers sensitivity to targeted therapy by echinomycin","volume":"40","author":"Peng","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Lo Dico, A., Martelli, C., Diceglie, C., Lucignani, G., and Ottobrini, L. (2018). Hypoxia-Inducible Factor-1\u03b1 Activity as a Switch for Glioblastoma Responsiveness to Temozolomide. Front. Oncol., 8.","DOI":"10.3389\/fonc.2018.00249"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1080\/15384047.2016.1139228","article-title":"Hypoxia regulates ABCG2 activity through the activivation of ERK1\/2\/HIF-1\u03b1 and contributes to chemoresistance in pancreatic cancer cells","volume":"17","author":"He","year":"2016","journal-title":"Cancer Biol. Ther."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e412","DOI":"10.1038\/cddis.2012.153","article-title":"BMP2 sensitizes glioblastoma stem-like cells to Temozolomide by affecting HIF-1 stability and MGMT expression","volume":"3","author":"Persano","year":"2012","journal-title":"Cell Death Dis."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.dnarep.2007.03.008","article-title":"MGMT: Key node in the battle against genotoxicity, carcinogenicity and apoptosis induced by alkylating agents","volume":"6","author":"Kaina","year":"2007","journal-title":"DNA Repair"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1158\/0008-5472.CAN-14-3616","article-title":"Minor Changes in Expression of the Mismatch Repair Protein MSH2 Exert a Major Impact on Glioblastoma Response to Temozolomide","volume":"75","author":"Braun","year":"2015","journal-title":"Cancer Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/mutage\/gez019","article-title":"Impact of hypoxia on DNA repair and genome integrity","volume":"35","author":"Kaplan","year":"2020","journal-title":"Mutagenesis"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"7965","DOI":"10.1038\/s41598-017-06086-2","article-title":"HIF1\u03b1 regulates glioma chemosensitivity through the transformation between differentiation and dedifferentiation in various oxygen levels","volume":"7","author":"Wang","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Zhou, D., Duan, Z., Li, Z., Ge, F., Wei, R., and Kong, L. (2022). The significance of glycolysis in tumor progression and its relationship with the tumor microenvironment. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.1091779"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"D\u2019Aprile, S., Denaro, S., Gervasi, A., Vicario, N., and Parenti, R. (2025). Targeting metabolic reprogramming in glioblastoma as a new strategy to overcome therapy resistance. Front. Cell Dev. Biol., 13.","DOI":"10.3389\/fcell.2025.1535073"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.neo.2020.12.009","article-title":"Glycolysis-induced drug resistance in tumors\u2014A response to danger signals?","volume":"23","author":"Marcucci","year":"2021","journal-title":"Neoplasia"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/s41467-021-21535-3","article-title":"The HIF-1\u03b1 antisense long non-coding RNA drives a positive feedback loop of HIF-1\u03b1 mediated transactivation and glycolysis","volume":"12","author":"Zheng","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_37","first-page":"1154","article-title":"Identification of the IncRNA HIF1A AS3 Biomarker and Analysis of Immune Infiltrates in Breast Cancer","volume":"4","author":"Yong","year":"2024","journal-title":"J. Oncol."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Steponaitis, G., and Tamasauskas, A. (2021). Mesenchymal and Proneural Subtypes of Glioblastoma Disclose Branching Based on GSC Associated Signature. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22094964"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1016\/j.celrep.2016.05.018","article-title":"The Long Non-coding RNA HIF1A-AS2 Facilitates the Maintenance of Mesenchymal Glioblastoma Stem-like Cells in Hypoxic Niches","volume":"15","author":"Mineo","year":"2016","journal-title":"Cell Rep."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3892\/br.2021.1461","article-title":"lncRNA HIF1A-AS2: A potential oncogene in human cancers (Review)","volume":"15","author":"Liu","year":"2021","journal-title":"Biomed. Rep."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Bronisz, A., Sali\u0144ska, E., Chiocca, E.A., and Godlewski, J. (2020). Hypoxic Roadmap of Glioblastoma-Learning about Directions and Distances in the Brain Tumor Environment. Cancers, 12.","DOI":"10.3390\/cancers12051213"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"587","DOI":"10.20892\/j.issn.2095-3941.2020.0209","article-title":"LncRNA HIF1A-AS2 accelerates malignant phenotypes of renal carcinoma by modulating miR-30a-5p\/SOX4 axis as a ceRNA","volume":"18","author":"Chen","year":"2021","journal-title":"Cancer Biol. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1158\/2326-6066.CIR-23-0622","article-title":"Hypoxia-Induced Long Noncoding RNA HIF1A-AS2 Regulates Stability of MHC Class I Protein in Head and Neck Cancer","volume":"12","author":"Liao","year":"2024","journal-title":"Cancer Immunol. Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/s41419-024-06958-2","article-title":"HIF1A-AS2 promotes the metabolic reprogramming and progression of colorectal cancer via miR-141-3p\/FOXC1 axis","volume":"15","author":"Zhong","year":"2024","journal-title":"Cell Death Dis."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.cell.2012.01.021","article-title":"Hypoxia-inducible factors in physiology and medicine","volume":"148","author":"Semenza","year":"2012","journal-title":"Cell"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"442","DOI":"10.2174\/156652409788167087","article-title":"Hypoxia and radiation therapy: Past history, ongoing research, and future promise","volume":"9","author":"Rockwell","year":"2009","journal-title":"Curr. Mol. Med."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Begagi\u0107, E., Be\u010duli\u0107, H., D\u017eidi\u0107-Krivi\u0107, A., Kadi\u0107 Vukas, S., Had\u017ei\u0107, S., Meki\u0107-Abazovi\u0107, A., \u0160egalo, S., Papi\u0107, E., Muchai Echengi, E., and Pugonja, R. (2024). Understanding the Significance of Hypoxia-Inducible Factors (HIFs) in Glioblastoma: A Systematic Review. Cancers, 16.","DOI":"10.3390\/cancers16112089"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"3274","DOI":"10.4161\/cc.8.20.9701","article-title":"The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype","volume":"8","author":"Heddleston","year":"2009","journal-title":"Cell Cycle"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"117619","DOI":"10.1016\/j.bcp.2025.117619","article-title":"Interplay between hypoxia-inducible factors and apoptosis in glioblastoma","volume":"244","author":"Rahman","year":"2026","journal-title":"Biochem. Pharmacol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1093\/brain\/awq042","article-title":"A hypoxic niche regulates glioblastoma stem cells through hypoxia inducible factor 2 alpha","volume":"133","author":"Seidel","year":"2010","journal-title":"Brain"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Bakleh, M.Z., and Al Haj Zen, A. (2025). The Distinct Role of HIF-1\u03b1 and HIF-2\u03b1 in Hypoxia and Angiogenesis. Cells, 14.","DOI":"10.3390\/cells14090673"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.ctrv.2015.05.004","article-title":"The emerging role of hypoxia-inducible factor-2 involved in chemo\/radioresistance in solid tumors","volume":"41","author":"Zhao","year":"2015","journal-title":"Cancer Treat. Rev."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"5220","DOI":"10.1111\/febs.13062","article-title":"Hypoxia-inducible factor-2\u03b1 (HIF-2\u03b1), but not HIF-1\u03b1, is essential for hypoxic induction of class III \u03b2-tubulin expression in human glioblastoma cells","volume":"281","author":"Bordji","year":"2014","journal-title":"FEBS J."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1073\/pnas.1314341111","article-title":"miR-218 opposes a critical RTK-HIF pathway in mesenchymal glioblastoma","volume":"111","author":"Mathew","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/j.celrep.2017.07.049","article-title":"CD44 Interacts with HIF-2\u03b1 to Modulate the Hypoxic Phenotype of Perinecrotic and Perivascular Glioma Cells","volume":"20","author":"Johansson","year":"2017","journal-title":"Cell Rep."},{"key":"ref_56","first-page":"21","article-title":"Hypoxia and hypoxia inducible factors in cancer stem cell maintenance","volume":"345","author":"Li","year":"2010","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1215\/S1152851704001061","article-title":"The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis","volume":"7","author":"Brat","year":"2005","journal-title":"Neuro-Oncology"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"103866","DOI":"10.1016\/j.redox.2025.103866","article-title":"Hydrogen sulfide inhibits recruitment of monocyte-derived tumor associated macrophages in glioblastoma by downregulating CXCL12","volume":"86","author":"Camarano","year":"2025","journal-title":"Redox Biol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.clineuro.2013.12.004","article-title":"The role of regulatory T-cells in glioma immunology","volume":"119","author":"Ooi","year":"2014","journal-title":"Clin. Neurol. Neurosurg."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/978-1-0716-4901-5_34","article-title":"Bioinformatics Analysis of Bc3, IL-8, and PD-L1 Gene Co-expression in Glioblastoma and Pan-Cancer Using Xena Platform","volume":"2983","author":"Reddy","year":"2026","journal-title":"Methods Mol. Biol."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Schwartzbaum, J., Wang, M., Root, E., Pietrzak, M., Rempala, G.A., Huang, R.P., Johannesen, T.B., and Grimsrud, T.K. (2017). A nested case-control study of 277 prediagnostic serum cytokines and glioma. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0178705"},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Gupta, M., and Rathored, J. (2024). Hyperbaric oxygen therapy: Future prospects in regenerative therapy and anti-aging. Front. Aging, 5.","DOI":"10.3389\/fragi.2024.1368982"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Jain, K.K. (2017). Physical, Physiological, and Biochemical Aspects of Hyperbaric Oxygenation. Textbook of Hyperbaric Medicine, Springer International Publishing.","DOI":"10.1007\/978-3-319-47140-2_2"},{"key":"ref_64","first-page":"Ra279","article-title":"Hyperbaric oxygen and malignancies: A potential role in radiotherapy, chemotherapy, tumor surgery and phototherapy","volume":"11","author":"Butler","year":"2005","journal-title":"Med. Sci. Monit."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1177\/147323001204000318","article-title":"The synergistic therapeutic effect of temozolomide and hyperbaric oxygen on glioma U251 cell lines is accompanied by alterations in vascular endothelial growth factor and multidrug resistance-associated protein-1 levels","volume":"40","author":"Lu","year":"2012","journal-title":"J. Int. Med. Res."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1080\/00498250802478313","article-title":"Increased distribution of carboplatin, an anti-cancer agent, to rat brains with the aid of hyperbaric oxygenation","volume":"38","author":"Suzuki","year":"2008","journal-title":"Xenobiotica"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2176\/nmc.49.193","article-title":"Pharmacokinetic investigation of increased efficacy against malignant gliomas of carboplatin combined with hyperbaric oxygenation","volume":"49","author":"Suzuki","year":"2009","journal-title":"Neurol. Med. Chir."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Kaina, B. (2023). Temozolomide, Procarbazine and Nitrosoureas in the Therapy of Malignant Gliomas: Update of Mechanisms, Drug Resistance and Therapeutic Implications. J. Clin. Med., 12.","DOI":"10.3390\/jcm12237442"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s12032-016-0814-0","article-title":"Hyperbaric oxygen as an adjunctive therapy in treatment of malignancies, including brain tumours","volume":"33","author":"Ostrowski","year":"2016","journal-title":"Med. Oncol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/s12935-025-03823-w","article-title":"HIF-1\u03b1 and HIF-2\u03b1: Synergistic regulation of glioblastoma malignant progression during hypoxia and apparent chemosensitization in response to hyperbaric oxygen","volume":"25","author":"Wang","year":"2025","journal-title":"Cancer Cell Int."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"8309","DOI":"10.3390\/cimb45100524","article-title":"Hyperbaric Oxygen Therapy Adjuvant Chemotherapy and Radiotherapy through Inhibiting Stemness in Glioblastoma","volume":"45","author":"Yuen","year":"2023","journal-title":"Curr. Issues Mol. Biol."},{"key":"ref_72","first-page":"2703","article-title":"Hyperbaric oxygen increases glioma cell sensitivity to antitumor treatment with a novel isothiourea derivative in vitro","volume":"41","author":"Zembrzuska","year":"2019","journal-title":"Oncol. Rep."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Wang, P., Wang, X.-Y., Man, C.-F., Gong, D.-D., and Fan, Y. (2023). Advances in hyperbaric oxygen to promote immunotherapy through modulation of the tumor microenvironment. Front. Oncol., 13.","DOI":"10.3389\/fonc.2023.1200619"},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Liao, B., Wang, P., Gong, S., Zhao, L., Liu, J., and Wu, N. (2025). Coordinated regulation of IGF1R by HIF1\u03b1 and HIF2\u03b1 enhances chemoresistance in glioblastoma. Front. Pharmacol., 16.","DOI":"10.3389\/fphar.2025.1575332"},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Gong, S., Wang, P., Liao, B., Zhao, L., and Wu, N. (2025). Hyperbaric oxygen promotes both the proliferation and chemosensitization of glioblastoma cells by inhibiting HIF1\u03b1\/HIF2\u03b1-ABCG2. Front. Mol. Neurosci., 18.","DOI":"10.3389\/fnmol.2025.1584407"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.bbabio.2009.03.009","article-title":"Response of blood vessels in vitro to hyperbaric oxygen (HBO): Modulation of VEGF and NO(x) release by external lactate or arginine","volume":"1787","author":"Yuan","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"887","DOI":"10.2217\/nnm-2017-0395","article-title":"Hyperbaric Oxygen as an Adjuvant to Temozolomide Nanoparticle Inhibits Glioma Growth by Inducing G2\/M Phase Arrest","volume":"13","author":"Xie","year":"2018","journal-title":"Nanomedicine"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s11060-007-9407-2","article-title":"Hyperoxia retards growth and induces apoptosis, changes in vascular density and gene expression in transplanted gliomas in nude rats","volume":"85","author":"Stuhr","year":"2007","journal-title":"J. Neuro-Oncol."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Alpuim Costa, D., Sampaio-Alves, M., Netto, E., Fernandez, G., Oliveira, E., Teixeira, A., Daniel, P.M., Bernardo, G.S., and Amaro, C. (2022). Hyperbaric Oxygen Therapy as a Complementary Treatment in Glioblastoma\u2014A Scoping Review. Front. Neurol., 13.","DOI":"10.3389\/fneur.2022.886603"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"44","DOI":"10.24966\/AND-9608\/100044","article-title":"Glioblastoma & Hyperbaric Oxygen Therapy","volume":"6","author":"Hooper","year":"2020","journal-title":"J. Alzheimer\u2019s Neurodegener. Dis."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Zhang, Y., Zhou, Y., Jia, Y., Wang, T., and Meng, D. (2023). Adverse effects of hyperbaric oxygen therapy: A systematic review and meta-analysis. Front. Med., 10.","DOI":"10.3389\/fmed.2023.1160774"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1700859","DOI":"10.1002\/advs.201700859","article-title":"Hyperbaric Oxygen Potentiates Doxil Antitumor Efficacy by Promoting Tumor Penetration and Sensitizing Cancer Cells","volume":"5","author":"Wu","year":"2018","journal-title":"Adv. Sci."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Yuen, C.-M., Tsai, H.-P., Tseng, T.-T., Tseng, Y.-L., Lieu, A.-S., Kwan, A.-L., and Chang, A.Y.W. (2024). Hyperbaric Oxygen Therapy as a Novel Approach to Modulating Macrophage Polarization for the Treatment of Glioblastoma. Biomedicines, 12.","DOI":"10.3390\/biomedicines12071383"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.wneu.2024.01.161","article-title":"Hyperbaric Oxygen Therapy as an Alternative Therapeutic Option for Radiation-Induced Necrosis Following Radiotherapy for Intracranial Pathologies","volume":"186","author":"Hajikarimloo","year":"2024","journal-title":"World Neurosurg."},{"key":"ref_85","first-page":"351","article-title":"Potential roles of hyperbaric oxygenation in the treatments of brain tumors","volume":"40","author":"Kohshi","year":"2013","journal-title":"Undersea Hyperb. Med."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/sj.bjc.6690345","article-title":"Effects of radiotherapy after hyperbaric oxygenation on malignant gliomas","volume":"80","author":"Kohshi","year":"1999","journal-title":"Br. J. Cancer"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.ijrobp.2010.12.070","article-title":"Phase II trial of radiotherapy after hyperbaric oxygenation with multiagent chemotherapy (procarbazine, nimustine, and vincristine) for high-grade gliomas: Long-term results","volume":"82","author":"Ogawa","year":"2012","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1093\/jrr\/rrw105","article-title":"Radiotherapy using IMRT boosts after hyperbaric oxygen therapy with chemotherapy for glioblastoma","volume":"58","author":"Yahara","year":"2017","journal-title":"J. Radiat. Res."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"bcr2016218148","DOI":"10.1136\/bcr-2016-218148","article-title":"Long-term stabilisation of myeloma with curcumin","volume":"2017","author":"Zaidi","year":"2017","journal-title":"BMJ Case Rep."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.radonc.2022.10.024","article-title":"Sensitizing brain metastases to stereotactic radiosurgery using hyperbaric oxygen: A proof-of-principle study","volume":"177","author":"Hartford","year":"2022","journal-title":"Radiother. Oncol."},{"key":"ref_91","first-page":"465","article-title":"Therapeutic effect of combined hyperbaric oxygen and radiation therapy for single brain metastasis and its influence on osteopontin and MMP-9","volume":"17","author":"Tao","year":"2019","journal-title":"Exp. Ther. Med."},{"key":"ref_92","unstructured":"King, S. (2026, July 20). Australian-First Brain Cancer Study to Test Hyperbaric Oxygen Therapy During Active Treatment. Available online: https:\/\/www.scu.edu.au\/news\/2026\/australian-first-brain-cancer-study-to-test-hyperbaric-oxygen-therapy-during-act\/."},{"key":"ref_93","first-page":"4467","article-title":"Effect of hyperbaric oxygen on the anticancer effect of artemisinin on molt-4 human leukemia cells","volume":"30","author":"Ohgami","year":"2010","journal-title":"Anticancer Res."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1002\/cam4.851","article-title":"Hyperbaric oxygen therapy sensitizes nimustine treatment for glioma in mice","volume":"5","author":"Lu","year":"2016","journal-title":"Cancer Med."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"879.4","DOI":"10.1096\/fasebj.31.1_supplement.879.4","article-title":"Anti-Cancer Effects of Ascorbic Acid and Hyperbaric Oxygen Therapy in vitro","volume":"31","author":"DeBlasi","year":"2017","journal-title":"FASEB J."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12951-019-0483-1","article-title":"Mild thermotherapy and hyperbaric oxygen enhance sensitivity of TMZ\/PSi nanoparticles via decreasing the stemness in glioma","volume":"17","author":"Zeng","year":"2019","journal-title":"J. Nanobiotechnol."},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Canarslan Demir, K., Avci, A.U., Ozgok Kangal, M.K., Ceylan, B., Abayli, S.Y., Ozler, I., and Yilmaz, K.B. (2025). Hyperbaric Oxygen Therapy for Managing Cancer Treatment Complications: A Safety Evaluation. Medicina, 61.","DOI":"10.3390\/medicina61030385"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s13014-022-02141-z","article-title":"Comparative analysis of the prognosis of external beam radiation therapy (EBRT) and EBRT plus brachytherapy for glioblastoma multiforme: A SEER population-based study","volume":"17","author":"Yang","year":"2022","journal-title":"Radiat. Oncol."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Mann, J., Ramakrishna, R., Magge, R., and Wernicke, A.G. (2017). Advances in Radiotherapy for Glioblastoma. Front. Neurol., 8.","DOI":"10.3389\/fneur.2017.00748"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1007\/s12094-020-02513-5","article-title":"Hyperbaric oxygen and radiation therapy: A review","volume":"23","author":"Morillo","year":"2021","journal-title":"Clin. Transl. Oncol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"vdaf255","DOI":"10.1093\/noajnl\/vdaf255","article-title":"Innovative radiotherapies for the treatment of glioblastoma","volume":"8","author":"Waked","year":"2026","journal-title":"Neuro-Oncol. Adv."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/jrr\/rrs070","article-title":"Radiobiological description of the LET dependence of the cell survival of oxic and anoxic cells irradiated by carbon ions","volume":"54","author":"Antonovic","year":"2013","journal-title":"J. Radiat. Res."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1667\/RADE-25-00093.1","article-title":"Impact of Oxygen on DNA Damage Distribution in 3D Genome and its Correlation to Oxygen Enhancement Ratio after High-LET Irradiation","volume":"205","author":"Hu","year":"2025","journal-title":"Radiat. Res."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"130","DOI":"10.4103\/mgr.MEDGASRES-D-23-00028","article-title":"Hyperbaric oxygen: A multifaceted approach in cancer therapy","volume":"14","author":"Deng","year":"2024","journal-title":"Med. Gas. Res."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/jrr\/rrt095","article-title":"High linear-energy-transfer radiation can overcome radioresistance of glioma stem-like cells to low linear-energy-transfer radiation","volume":"55","author":"Hirota","year":"2014","journal-title":"J. Radiat. Res."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"118703","DOI":"10.1016\/j.biopha.2025.118703","article-title":"Breaking the hypoxia barrier: Advances and challenges of hyperbaric oxygen therapy in cancer treatment","volume":"193","author":"Meng","year":"2025","journal-title":"Biomed. Pharmacother."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s00432-024-05757-8","article-title":"A perspective on tumor radiation resistance following high-LET radiation treatment","volume":"150","author":"Rajpurohit","year":"2024","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"615","DOI":"10.3109\/09553002.2014.892227","article-title":"Cancer stem cells and radioresistance","volume":"90","author":"Rycaj","year":"2014","journal-title":"Int. J. Radiat. Biol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"24","DOI":"10.4103\/2045-9912.229600","article-title":"Hyperbaric oxygen therapy as adjunctive strategy in treatment of glioblastoma multiforme","volume":"8","author":"Huang","year":"2018","journal-title":"Med. Gas. Res."},{"key":"ref_110","first-page":"3833","article-title":"Hyperbaric oxygen inhibits benign and malignant human mammary epithelial cell proliferation","volume":"25","author":"Granowitz","year":"2005","journal-title":"Anticancer Res."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2174\/1874467211205010102","article-title":"Temozolomide: Mechanisms of action, repair and resistance","volume":"5","author":"Zhang","year":"2012","journal-title":"Curr. Mol. Pharmacol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.3171\/2016.6.JNS152797","article-title":"Association of collagen architecture with glioblastoma patient survival","volume":"126","author":"Pointer","year":"2016","journal-title":"J. Neurosurg."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"10607","DOI":"10.1021\/acs.nanolett.6c01219","article-title":"Enhanced Glioblastoma Targeting and Penetration: Extracellular Matrix Remodeling by Collagenase-Functionalized Ferumoxytol Nanoparticles","volume":"26","author":"Wang","year":"2026","journal-title":"Nano Lett."},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Oliva, C.R., Moellering, D.R., Gillespie, G.Y., and Griguer, C.E. (2011). Acquisition of Chemoresistance in Gliomas Is Associated with Increased Mitochondrial Coupling and Decreased ROS Production. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0024665"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s13046-023-02686-1","article-title":"Piperlongumine conquers temozolomide chemoradiotherapy resistance to achieve immune cure in refractory glioblastoma via boosting oxidative stress-inflamation-CD8+-T cell immunity","volume":"42","author":"Liu","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Schottlender, N., Gottfried, I., and Ashery, U. (2021). Hyperbaric Oxygen Treatment: Effects on Mitochondrial Function and Oxidative Stress. Biomolecules, 11.","DOI":"10.3390\/biom11121827"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"viii132","DOI":"10.1093\/neuonc\/noae165.0516","article-title":"Dddr-31. The Chemotherapeutic Activity of Temozolomide Is Antagonized by Its Hydrolysis Product, Aic","volume":"26","author":"Sowers","year":"2024","journal-title":"Neuro-Oncology"},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Altanam, S.Y., Darwish, N., and Bakillah, A. (2025). Exploring the Interplay of Antioxidants, Inflammation, and Oxidative Stress: Mechanisms, Therapeutic Potential, and Clinical Implications. Diseases, 13.","DOI":"10.3390\/diseases13090309"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/s41419-026-08729-7","article-title":"Hypoxia-induced BTN3A2 promotes glioma progression and chemoresistance via AKT\/SP1\/RAD51-mediated DNA damage","volume":"17","author":"Xu","year":"2026","journal-title":"Cell Death Dis."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s11060-012-0923-3","article-title":"Hyperoxia resensitizes chemoresistant human glioblastoma cells to temozolomide","volume":"109","author":"Sun","year":"2012","journal-title":"J. Neuro-Oncol."},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Harrison, D.K., and Delpy, D.T. (1997). Tumor oxygenation under normobaric and hyperbaric hyperoxia. Oxygen Transport to Tissue XIX, Springer.","DOI":"10.1007\/978-1-4615-5399-1"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.critrevonc.2016.01.018","article-title":"Therapeutic options in recurrent glioblastoma\u2014An update","volume":"99","author":"Seystahl","year":"2016","journal-title":"Crit. Rev. Oncol.\/Hematol."},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"Elgemeie, G.H., and Mohamed-Ezzat, R.A. (2022). Chapter 8\u2014Anticancer alkylating agents. New Strategies Targeting Cancer Metabolism, Elsevier.","DOI":"10.1016\/B978-0-12-821783-2.00003-0"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.3892\/ijo_00000424","article-title":"Efficacy and mechanism of anti-tumor action of new potential CK2 inhibitors toward glioblastoma cells","volume":"35","author":"Kaminska","year":"2009","journal-title":"Int. J. Oncol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.1007\/s00044-011-9841-8","article-title":"Proapoptotic effects of novel pentabromobenzylisothioureas in human leukemia cell lines","volume":"21","author":"Koronkiewicz","year":"2012","journal-title":"Med. Chem. Res."},{"key":"ref_126","first-page":"4891","article-title":"Synergistic anti-leukemic effects of CK2 inhibitors and pentabromobenzylisothioureas in vitro","volume":"33","author":"Koronkiewicz","year":"2013","journal-title":"Anticancer Res."},{"key":"ref_127","first-page":"1325","article-title":"Proapoptotic effects of new pentabromobenzylisothiouronium salts in a human prostate adenocarcinoma cell line","volume":"69","author":"Koronkiewicz","year":"2012","journal-title":"Acta Pol. Pharm."},{"key":"ref_128","first-page":"2691","article-title":"Potent Antitumour Effects of Novel Pentabromobenzylisothioureas Studied on Human Glial-derived Tumour Cell Lines","volume":"38","author":"Pucko","year":"2018","journal-title":"Anticancer Res."},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Dardet, J.P., Serrano, N., Andr\u00e1s, I.E., and Toborek, M. (2022). Overcoming Blood-Brain Barrier Resistance: Implications for Extracellular Vesicle-Mediated Drug Brain Delivery. Front. Drug Deliv., 2.","DOI":"10.3389\/fddev.2022.855017"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s40824-023-00360-3","article-title":"Albumin-binding photosensitizer capable of targeting glioma via the SPARC pathway","volume":"27","author":"Li","year":"2023","journal-title":"Biomater. Res."},{"key":"ref_131","doi-asserted-by":"crossref","unstructured":"Saint-Pol, J., Gosselet, F., Duban-Deweer, S., Pottiez, G., and Karamanos, Y. (2020). Targeting and Crossing the Blood-Brain Barrier with Extracellular Vesicles. Cells, 9.","DOI":"10.3390\/cells9040851"},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Zhang, S., Zhou, J., Liu, J., Li, T., Liu, Y., and Gao, Y. (2025). Hyperbaric oxygen in combination with exosomes: A new strategy to promote tissue repair. Front. Bioeng. Biotechnol., 13, Erratum in Front. Bioeng. Biotechnol.\u00a02025, 13, 1727054.","DOI":"10.3389\/fbioe.2025.1639060"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12987-024-00543-7","article-title":"Exposure to hyperbaric O(2) levels leads to blood-brain barrier breakdown in rodents","volume":"21","author":"Danino","year":"2024","journal-title":"Fluids Barriers CNS"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.brainres.2013.07.052","article-title":"The effects of hyperbaric air and hyperbaric oxygen on blood-brain barrier integrity in rats","volume":"1531","author":"Cevik","year":"2013","journal-title":"Brain Res."},{"key":"ref_135","first-page":"1","article-title":"Chapter 1\u2014Pathways linked to cancer chemoresistance and their targeting by nutraceuticals","volume":"Volume 2","author":"Bharti","year":"2018","journal-title":"Role of Nutraceuticals in Cancer Chemosensitization"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"21042","DOI":"10.1039\/D6RA01841F","article-title":"Catalytic asymmetric acylation reactions using isothiourea catalysts: A Decade\u2019s update","volume":"16","author":"Khatua","year":"2026","journal-title":"RSC Adv."},{"key":"ref_137","doi-asserted-by":"crossref","unstructured":"Noce, B., Di Bello, E., Fioravanti, R., and Mai, A. (2023). LSD1 inhibitors for cancer treatment: Focus on multi-target agents and compounds in clinical trials. Front. Pharmacol., 14.","DOI":"10.3389\/fphar.2023.1120911"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"5197","DOI":"10.1021\/jm100217a","article-title":"(Bis)urea and (bis)thiourea inhibitors of lysine-specific demethylase 1 as epigenetic modulators","volume":"53","author":"Sharma","year":"2010","journal-title":"J. Med. Chem."},{"key":"ref_139","doi-asserted-by":"crossref","unstructured":"Yang, G.J., Lei, P.M., Wong, S.Y., Ma, D.L., and Leung, C.H. (2018). Pharmacological Inhibition of LSD1 for Cancer Treatment. Molecules, 23.","DOI":"10.3390\/molecules23123194"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s12672-025-02567-3","article-title":"Glioblastoma multiforme: An updated overview of temozolomide resistance mechanisms and strategies to overcome resistance","volume":"16","author":"Pu","year":"2025","journal-title":"Discov. Oncol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1093\/neuonc\/noad018","article-title":"Lysine-specific histone demethylase 1A (KDM1A\/LSD1) inhibition attenuates DNA double-strand break repair and augments the efficacy of temozolomide in glioblastoma","volume":"25","author":"Alejo","year":"2023","journal-title":"Neuro-Oncology"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1038\/onc.2016.395","article-title":"Novel KDM1A inhibitors induce differentiation and apoptosis of glioma stem cells via unfolded protein response pathway","volume":"36","author":"Sareddy","year":"2017","journal-title":"Oncogene"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"108596","DOI":"10.1016\/j.isci.2023.108596","article-title":"KDM5B predicts temozolomide-resistant subclones in glioblastoma","volume":"27","author":"Ullrich","year":"2024","journal-title":"iScience"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.bbrc.2014.10.078","article-title":"Overexpressed KDM5B is associated with the progression of glioma and promotes glioma cell growth via downregulating p21","volume":"454","author":"Dai","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1590\/S0102-86502012000600005","article-title":"Combination hyperbaric oxygen and temozolomide therapy in C6 rat glioma model","volume":"27","author":"Karaca","year":"2012","journal-title":"Acta Cir. Bras."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.molcel.2005.02.015","article-title":"HIF-1alpha induces genetic instability by transcriptionally downregulating MutSalpha expression","volume":"17","author":"Koshiji","year":"2005","journal-title":"Mol. Cell"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"4347","DOI":"10.1158\/0008-5472.CAN-07-2970","article-title":"Artesunate derived from traditional Chinese medicine induces DNA damage and repair","volume":"68","author":"Li","year":"2008","journal-title":"Cancer Res."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"107706","DOI":"10.1016\/j.pharmthera.2020.107706","article-title":"Artemisinins as a novel anti-cancer therapy: Targeting a global cancer pandemic through drug repurposing","volume":"216","author":"Augustin","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"ref_149","doi-asserted-by":"crossref","unstructured":"Li, Z., Li, Q., Wu, J., Wang, M., and Yu, J. (2016). Artemisinin and Its Derivatives as a Repurposing Anticancer Agent: What Else Do We Need to Do?. Molecules, 21.","DOI":"10.3390\/molecules21101331"},{"key":"ref_150","doi-asserted-by":"crossref","unstructured":"Wen, L., Chan, B.C.-L., Qiu, M.-H., Leung, P.-C., and Wong, C.-K. (2024). Artemisinin and Its Derivatives as Potential Anticancer Agents. Molecules, 29.","DOI":"10.3390\/molecules29163886"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1002\/med.21446","article-title":"Artemisinin as an anticancer drug: Recent advances in target profiling and mechanisms of action","volume":"37","author":"Wong","year":"2017","journal-title":"Med. Res. Rev."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1158\/1535-7163.MCT-11-0534","article-title":"Artesunate induces oxidative DNA damage, sustained DNA double-strand breaks, and the ATM\/ATR damage response in cancer cells","volume":"10","author":"Berdelle","year":"2011","journal-title":"Mol. Cancer Ther."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3109\/10408441003610571","article-title":"Toxicity of the antimalarial artemisinin and its dervatives","volume":"40","author":"Efferth","year":"2010","journal-title":"Crit. Rev. Toxicol."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.toxlet.2003.12.009","article-title":"Artemisinin derivatives: Toxic for laboratory animals, safe for humans?","volume":"147","author":"Gordi","year":"2004","journal-title":"Toxicol. Lett."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"EMMM202216959","DOI":"10.15252\/emmm.202216959","article-title":"A whole-genome scan for Artemisinin cytotoxicity reveals a novel therapy for human brain tumors","volume":"15","author":"Orthofer","year":"2023","journal-title":"EMBO Mol. Med."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"BSR20193314","DOI":"10.1042\/BSR20193314","article-title":"Dihydroartemisinin initiates ferroptosis in glioblastoma through GPX4 inhibition","volume":"40","author":"Yi","year":"2020","journal-title":"Biosci. Rep."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s13555-018-0221-x","article-title":"Nutraceuticals: A Review","volume":"8","author":"Souyoul","year":"2018","journal-title":"Dermatol. Ther."},{"key":"ref_158","doi-asserted-by":"crossref","unstructured":"Burgess, E.R., Crake, R.L.I., Phillips, E., Morrin, H.R., Royds, J.A., Slatter, T.L., Wiggins, G.A.R., Vissers, M.C.M., Robinson, B.A., and Dachs, G.U. (2022). Increased Ascorbate Content of Glioblastoma Is Associated with a Suppressed Hypoxic Response and Improved Patient Survival. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.829524"},{"key":"ref_159","doi-asserted-by":"crossref","unstructured":"Beltzig, L., Frumkina, A., Schwarzenbach, C., and Kaina, B. (2021). Cytotoxic, Genotoxic and Senolytic Potential of Native and Micellar Curcumin. Nutrients, 13.","DOI":"10.3390\/nu13072385"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.phrs.2018.11.005","article-title":"Curcumin in combination with anti-cancer drugs: A nanomedicine review","volume":"139","author":"Batra","year":"2019","journal-title":"Pharmacol. Res."},{"key":"ref_161","doi-asserted-by":"crossref","unstructured":"Zoi, V., Galani, V., Lianos, G.D., Voulgaris, S., Kyritsis, A.P., and Alexiou, G.A. (2021). The Role of Curcumin in Cancer Treatment. Biomedicines, 9.","DOI":"10.3390\/biomedicines9091086"},{"key":"ref_162","doi-asserted-by":"crossref","unstructured":"Kotha, R.R., and Luthria, D.L. (2019). Curcumin: Biological, Pharmaceutical, Nutraceutical, and Analytical Aspects. Molecules, 24.","DOI":"10.3390\/molecules24162930"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1002\/ptr.6642","article-title":"Potential therapeutic effects of curcumin mediated by JAK\/STAT signaling pathway: A review","volume":"34","author":"Ashrafizadeh","year":"2020","journal-title":"Phytother. Res."},{"key":"ref_164","doi-asserted-by":"crossref","unstructured":"Walker, B.C., and Mittal, S. (2020). Antitumor Activity of Curcumin in Glioblastoma. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21249435"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.3892\/or.2014.3342","article-title":"Curcumin sensitizes glioblastoma to temozolomide by simultaneously generating ROS and disrupting AKT\/mTOR signaling","volume":"32","author":"Yin","year":"2014","journal-title":"Oncol. Rep."},{"key":"ref_166","doi-asserted-by":"crossref","unstructured":"Zoi, V., Galani, V., Tsekeris, P., Kyritsis, A.P., and Alexiou, G.A. (2022). Radiosensitization and Radioprotection by Curcumin in Glioblastoma and Other Cancers. Biomedicines, 10.","DOI":"10.3390\/biomedicines10020312"},{"key":"ref_167","doi-asserted-by":"crossref","unstructured":"Zoi, V., Galani, V., Vartholomatos, E., Zacharopoulou, N., Tsoumeleka, E., Gkizas, G., Bozios, G., Tsekeris, P., Chousidis, I., and Leonardos, I. (2021). Curcumin and Radiotherapy Exert Synergistic Anti-Glioma Effect In Vitro. Biomedicines, 9.","DOI":"10.3390\/biomedicines9111562"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1002\/mnfr.200900277","article-title":"Curcumin inhibits tumor growth and angiogenesis in glioblastoma xenografts","volume":"54","author":"Perry","year":"2010","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_169","doi-asserted-by":"crossref","unstructured":"Bonaf\u00e9, G.A., Boschiero, M.N., Sodr\u00e9, A.R., Ziegler, J.V., Rocha, T., and Ortega, M.M. (2021). Natural Plant Compounds: Does Caffeine, Dipotassium Glycyrrhizinate, Curcumin, and Euphol Play Roles as Antitumoral Compounds in Glioblastoma Cell Lines?. Front. Neurol., 12.","DOI":"10.3389\/fneur.2021.784330"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1177\/1758834016643518","article-title":"Investigating the therapeutic role and molecular biology of curcumin as a treatment for glioblastoma","volume":"8","author":"Rodriguez","year":"2016","journal-title":"Ther. Adv. Med. Oncol."},{"key":"ref_171","doi-asserted-by":"crossref","unstructured":"Ryskalin, L., Biagioni, F., Busceti, C.L., Lazzeri, G., Frati, A., and Fornai, F. (2020). The Multi-Faceted Effect of Curcumin in Glioblastoma from Rescuing Cell Clearance to Autophagy-Independent Effects. Molecules, 25.","DOI":"10.3390\/molecules25204839"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1124\/jpet.110.168344","article-title":"Curcumin stimulates reactive oxygen species production and potentiates apoptosis induction by the antitumor drugs arsenic trioxide and lonidamine in human myeloid leukemia cell lines","volume":"335","author":"Aller","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"714","DOI":"10.36468\/pharmaceutical-sciences.822","article-title":"Curcumin Induces Human Glioma Cell Apoptosis by Promoting Reactive Oxygen Species Production","volume":"83","author":"Zhou","year":"2021","journal-title":"Indian J. Pharm. Sci."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"5424411","DOI":"10.1155\/2022\/5424411","article-title":"Curcumin Enhanced Ionizing Radiation-Induced Immunogenic Cell Death in Glioma Cells through Endoplasmic Reticulum Stress Signaling Pathways","volume":"2022","author":"Xiu","year":"2022","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1093\/jrr\/rrac016","article-title":"Interaction of curcumin with glioblastoma cells via high and low linear energy transfer radiation therapy inducing radiosensitization effects","volume":"63","author":"Kim","year":"2022","journal-title":"J. Radiat. Res."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"145","DOI":"10.61186\/ijrr.22.1.145","article-title":"The effect of curcumin in combination with radiation therapy and hyperthermia for a glioblastoma spheroid model","volume":"22","author":"Ghanbari","year":"2024","journal-title":"Int. J. Radiat. Res."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00432-020-03432-2","article-title":"Experimental and clinical studies on radiation and curcumin in human glioma","volume":"147","author":"Sminia","year":"2021","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_178","doi-asserted-by":"crossref","unstructured":"Rahman, M.A., Yadab, M.K., and Ali, M.M. (2026). Therapeutic Advances of Curcumin and Nanocurcumin in Glioblastoma: Molecular Targets, Bioavailability, and Drug Delivery. Nutrients, 18.","DOI":"10.3390\/nu18020194"},{"key":"ref_179","doi-asserted-by":"crossref","unstructured":"Nowacka, A., Zi\u00f3\u0142kowska, E., Smuczy\u0144ski, W., Bo\u017ci\u0142ow, D., and \u015aniegocki, M. (2025). Potential of Curcumin and Its Analogs in Glioblastoma Therapy. Antioxidants, 14.","DOI":"10.3390\/antiox14030351"},{"key":"ref_180","doi-asserted-by":"crossref","unstructured":"Maiti, P., Plemmons, A., and Dunbar, G.L. (2019). Combination treatment of berberine and solid lipid curcumin particles increased cell death and inhibited PI3K\/Akt\/mTOR pathway of human cultured glioblastoma cells more effectively than did individual treatments. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0225660"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1080\/01635581.2020.1771384","article-title":"Curcumin Administered as Micellar Solution Suppresses Intestinal Inflammation and Colorectal Carcinogenesis","volume":"73","author":"Seiwert","year":"2021","journal-title":"Nutr. Cancer"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1038\/s41598-018-20179-6","article-title":"Curcumin targets multiple enzymes involved in the ROS metabolic pathway to suppress tumor cell growth","volume":"8","author":"Larasati","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_183","doi-asserted-by":"crossref","unstructured":"Wolnicka-Glubisz, A., and Wisniewska-Becker, A. (2023). Dual Action of Curcumin as an Anti- and Pro-Oxidant from a Biophysical Perspective. Antioxidants, 12.","DOI":"10.3390\/antiox12091725"},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ejphar.2015.11.019","article-title":"Dual effect of curcumin targets reactive oxygen species, adenosine triphosphate contents and intermediate steps of mitochondria-mediated apoptosis in lung cancer cell lines","volume":"769","author":"Hosseinzadehdehkordi","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"ref_185","doi-asserted-by":"crossref","unstructured":"Nakamae, I., Morimoto, T., Shima, H., Shionyu, M., Fujiki, H., Yoneda-Kato, N., Yokoyama, T., Kanaya, S., Kakiuchi, K., and Shirai, T. (2019). Curcumin Derivatives Verify the Essentiality of ROS Upregulation in Tumor Suppression. Molecules, 24.","DOI":"10.3390\/molecules24224067"},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"6371","DOI":"10.1002\/jcp.27370","article-title":"Curcumin induces concentration-dependent alterations in mitochondrial function through ROS in C2C12 mouse myoblasts","volume":"234","author":"Yu","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"ref_187","doi-asserted-by":"crossref","unstructured":"Chen, H.W., Chen, S.D., Wu, H.T., Cheng, C.H., Chiou, C.S., and Chen, W.T. (2024). Improvement in Curcumin\u2019s Stability and Release by Formulation in Flexible Nano-Liposomes. Nanomaterials, 14.","DOI":"10.3390\/nano14221836"},{"key":"ref_188","doi-asserted-by":"crossref","unstructured":"Piwowarczyk, L., Mlynarczyk, D.T., Krajka-Ku\u017aniak, V., Majchrzak-Celi\u0144ska, A., Budzianowska, A., Tomczak, S., Budzianowski, J., Wo\u017aniak-Braszak, A., Pietrzyk, R., and Baranowski, M. (2022). Natural Compounds in Liposomal Nanoformulations of Potential Clinical Application in Glioblastoma. Cancers, 14.","DOI":"10.3390\/cancers14246222"},{"key":"ref_189","doi-asserted-by":"crossref","unstructured":"Salehi, B., Calina, D., Docea, A.O., Koirala, N., Aryal, S., Lombardo, D., Pasqua, L., Taheri, Y., Marina Salgado Castillo, C., and Martorell, M. (2020). Curcumin\u2019s Nanomedicine Formulations for Therapeutic Application in Neurological Diseases. J. Clin. Med., 9.","DOI":"10.3390\/jcm9020430"},{"key":"ref_190","doi-asserted-by":"crossref","unstructured":"Rinaldi, M., Caffo, M., Minutoli, L., Marini, H., Abbritti, R.V., Squadrito, F., Trichilo, V., Valenti, A., Barresi, V., and Altavilla, D. (2016). ROS and Brain Gliomas: An Overview of Potential and Innovative Therapeutic Strategies. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17060984"},{"key":"ref_191","doi-asserted-by":"crossref","unstructured":"Lee, H.-Y., Kang, S., Paik, J.-H., Ahn, T.-K., Seo, Y.-H., Kim, H., Cha, Y.-S., and Lee, Y. (2024). Characteristics of Side Effects in Non-Emergency Indications Using Computer-Controlled Pressurized Monoplace Hyperbaric Chambers: A Retrospective Multicenter Study. J. Clin. Med., 13.","DOI":"10.20944\/preprints202410.1293.v1"},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1089\/wound.2016.0718","article-title":"Hyperbaric Oxygen Therapy: Side Effects Defined and Quantified","volume":"6","author":"Heyboer","year":"2017","journal-title":"Adv. Wound Care"},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"343","DOI":"10.28920\/dhm55.4.343-351","article-title":"Hyperbaric oxygen treatment and pulmonary air-containing lesions","volume":"55","author":"Arslan","year":"2025","journal-title":"Diving Hyperb. Med."},{"key":"ref_194","doi-asserted-by":"crossref","unstructured":"Park, S., Marinov, A., Clarke, H., Schiavo, S., Greer, E., Djaiani, G., Tarshis, J., and Katznelson, R. (2025). Safety of hyperbaric oxygen therapy in non-emergent patients with a history of seizures: A retrospective cohort study. PLoS ONE, 20.","DOI":"10.1371\/journal.pone.0317586"},{"key":"ref_195","doi-asserted-by":"crossref","unstructured":"Shi, J., Zhao, H., Yan, C., Zhu, P., Zhu, Q., Ding, W., Wang, L., Zhao, Y., Wang, Y., and Fang, Y. (2026). Acute Lung Injury Induced by Hyperbaric Oxygen or Other External Factors, with a Focus on Exosomes. Int. J. Mol. Sci., 27.","DOI":"10.3390\/ijms27020836"},{"key":"ref_196","doi-asserted-by":"crossref","unstructured":"Wang, S., Chen, H., Li, Z., Xu, G., and Bao, X. (2024). Hyperbaric oxygen-induced acute lung injury: A mouse model study on pathogenic characteristics and recovery dynamics. Front. Physiol., 15.","DOI":"10.3389\/fphys.2024.1474933"},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1038\/s41433-023-02840-1","article-title":"Ocular effects of hyperbaric oxygen therapy","volume":"38","author":"Rivolta","year":"2024","journal-title":"Eye"},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"6","DOI":"10.33696\/Ophthalmology.5.022","article-title":"Rapid-onset Bilateral Cataracts after Hyperbaric Oxygen Therapy: A Case Report","volume":"5","author":"Lane","year":"2026","journal-title":"Arch. Clin. Ophthalmol."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"100417","DOI":"10.1016\/j.xops.2023.100417","article-title":"Oxygenation Fluctuations Associated with Severe Retinopathy of Prematurity: Insights from a Multimodal Deep Learning Approach","volume":"4","author":"Lin","year":"2024","journal-title":"Ophthalmol. Sci."},{"key":"ref_200","doi-asserted-by":"crossref","unstructured":"Andrews, S.R., and Harch, P.G. (2024). Systematic review and dosage analysis: Hyperbaric oxygen therapy efficacy in the treatment of posttraumatic stress disorder. Front. Neurol., 15.","DOI":"10.3389\/fneur.2024.1360311"},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/aorn.12097","article-title":"Hyperbaric Oxygen Therapy: Indications, Contraindications, and Use at a Tertiary Care Center: 1.3 www.aornjournal.org\/content\/cme","volume":"107","author":"Howell","year":"2018","journal-title":"AORN J."},{"key":"ref_202","unstructured":"D\u2019Almeida, A.G., and Hidalgo, J. (2025). Clinical evaluation of patients proposed for hyperbaric oxygen therapy and contraindications. Evidence-Based Hyperbaric Medicine: Concepts and Clinical Application, Springer Nature."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"e873","DOI":"10.1002\/ams2.873","article-title":"Narrative minireview of the current status of hyperbaric oxygen therapy for pregnant women","volume":"10","author":"Yanagawa","year":"2023","journal-title":"Acute Med. Surg."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"42","DOI":"10.28920\/dhm53.1.42-50","article-title":"Safety and performance of intravenous pumps and syringe drivers in hyperbaric environments","volume":"53","author":"Smart","year":"2023","journal-title":"Diving Hyperb. Med."},{"key":"ref_205","first-page":"223","article-title":"Medical devices and procedures in the hyperbaric chamber","volume":"44","author":"Kot","year":"2014","journal-title":"Diving Hyperb. Med."},{"key":"ref_206","first-page":"A372","article-title":"1640a Qualification and requirements for hyperbaric chamber facility personnel","volume":"75","author":"Gonevski","year":"2018","journal-title":"Occup. Environ. Med."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2478\/phr-2020-0001","article-title":"Formal and Professional Requirements for Medical, Paramedical and Technical Staff of Hyperbaric Centres. Part 2","volume":"70","author":"Siermontowski","year":"2020","journal-title":"Pol. Hyperb. Res."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.1007\/s12094-026-04290-z","article-title":"Efficacy of concurrent hyperbaric oxygen therapy with chemoradiotherapy for glioma: A meta-analysis","volume":"28","author":"Cui","year":"2026","journal-title":"Clin. Transl. Oncol."},{"key":"ref_209","first-page":"1","article-title":"Hyperbaric oxygen: Does it promote growth or recurrence of malignancy?","volume":"30","author":"Feldmeier","year":"2003","journal-title":"Undersea Hyperb. Med."},{"key":"ref_210","doi-asserted-by":"crossref","unstructured":"Gozdz, A., Wojta\u015b, B., Szpak, P., Szadkowska, P., Czernicki, T., Marchel, A., W\u00f3jtowicz, K., Kaspera, W., Ladzinski, P., and Szopa, W. (2022). Preservation of the Hypoxic Transcriptome in Glioblastoma Patient-Derived Cell Lines Maintained at Lowered Oxygen Tension. Cancers, 14.","DOI":"10.3390\/cancers14194852"},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.cell.2007.01.047","article-title":"HIF-1 Regulates Cytochrome Oxidase Subunits to Optimize Efficiency of Respiration in Hypoxic Cells","volume":"129","author":"Fukuda","year":"2007","journal-title":"Cell"},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.1038\/s41598-017-03980-7","article-title":"HIF-1-mediated suppression of mitochondria electron transport chain function confers resistance to lidocaine-induced cell death","volume":"7","author":"Okamoto","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1161\/STROKEAHA.107.490599","article-title":"Hyperbaric Oxygen Reduces Tissue Hypoxia and Hypoxia-Inducible Factor-1\u03b1 Expression in Focal Cerebral Ischemia","volume":"39","author":"Sun","year":"2008","journal-title":"Stroke"},{"key":"ref_214","doi-asserted-by":"crossref","unstructured":"Lee, S.H., Golinska, M., and Griffiths, J.R. (2021). HIF-1-Independent Mechanisms Regulating Metabolic Adaptation in Hypoxic Cancer Cells. Cells, 10.","DOI":"10.3390\/cells10092371"},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"57813","DOI":"10.18632\/oncotarget.18175","article-title":"The reverse Warburg effect is likely to be an Achilles\u2019 heel of cancer that can be exploited for cancer therapy","volume":"8","author":"Fu","year":"2017","journal-title":"Oncotarget"},{"key":"ref_216","doi-asserted-by":"crossref","unstructured":"Barba, I., Carrillo-Bosch, L., and Seoane, J. (2024). Targeting the Warburg Effect in Cancer: Where Do We Stand?. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25063142"},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"8927","DOI":"10.1158\/0008-5472.CAN-06-1501","article-title":"Cancer\u2019s molecular sweet tooth and the Warburg effect","volume":"66","author":"Kim","year":"2006","journal-title":"Cancer Res."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.apsb.2023.12.003","article-title":"Targeting the Warburg effect: A revisited perspective from molecular mechanisms to traditional and innovative therapeutic strategies in cancer","volume":"14","author":"Liao","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.canlet.2018.03.046","article-title":"RIP1 and RIP3 contribute to shikonin-induced glycolysis suppression in glioma cells via increase of intracellular hydrogen peroxide","volume":"425","author":"Lu","year":"2018","journal-title":"Cancer Lett."},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"4452","DOI":"10.1158\/1078-0432.CCR-15-2274","article-title":"Myc-Driven Glycolysis Is a Therapeutic Target in Glioblastoma","volume":"22","author":"Tateishi","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"69518","DOI":"10.18632\/oncotarget.11680","article-title":"Targeting hexokinase 2 enhances response to radio-chemotherapy in glioblastoma","volume":"7","author":"Vartanian","year":"2016","journal-title":"Oncotarget"},{"key":"ref_222","doi-asserted-by":"crossref","unstructured":"Yang, L., Li, S., Yu, L., Leng, J., and Li, N. (2024). Targeting glycolysis: Exploring a new frontier in glioblastoma therapy. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1522392"},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"100985","DOI":"10.1016\/j.neo.2024.100985","article-title":"Advancing glioblastoma treatment by targeting metabolism","volume":"51","author":"Zhao","year":"2024","journal-title":"Neoplasia"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/19\/8504\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T04:22:39Z","timestamp":1790310159000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/19\/8504"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,23]]},"references-count":223,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["ijms27198504"],"URL":"https:\/\/doi.org\/10.3390\/ijms27198504","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,23]]}}}